Allen Capital Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,467
Closed -$222K 271
2025
Q1
$222K Buy
+2,467
New +$221K 0.03% 229
2024
Q4
Sell
-2,880
Closed -$259K 227
2024
Q3
$259K Buy
+2,880
New +$242K 0.03% 204
2022
Q4
Sell
-2,669
Closed -$216K 108
2022
Q3
$216K Hold
2,669
0.05% 151
2022
Q2
$240K Sell
2,669
-288
-10% -$29.2K 0.05% 140
2022
Q1
$328K Sell
2,957
-10
-0.3% -$1.06K 0.06% 135
2021
Q4
$307K Buy
2,967
+1
+0% +$116 0.04% 138
2021
Q3
$372K Buy
2,966
+12
+0.4% +$1.55K 0.07% 117
2021
Q2
$367K Sell
2,954
-323
-10% -$40.6K 0.07% 118
2021
Q1
$387K Buy
3,277
+26
+0.8% +$3.05K 0.09% 114
2020
Q4
$381K Hold
3,251
0.09% 107
2020
Q3
$348K Hold
3,251
0.09% 108
2020
Q2
$298K Hold
3,251
0.08% 110
2020
Q1
$293K Sell
3,251
-454
-12% -$48.3K 0.09% 106
2019
Q4
$420K Hold
3,705
0.11% 104
2019
Q3
$396K Buy
3,705
+995
+37% +$104K 0.12% 101
2019
Q2
$264K Sell
2,710
-573
-17% -$52.3K 0.09% 111
2019
Q1
$299K Sell
3,283
-23
-0.7% -$2.06K 0.1% 102
2018
Q4
$289K Hold
3,306
0.1% 101
2018
Q3
$325K Buy
3,306
+23
+0.7% +$2.13K 0.11% 99
2018
Q2
$281K Buy
+3,283
New +$274K 0.1% 103

Other funds holding MDT

Allen Capital Group's MDT Position: Q2 2025 in Review

Allen Capital Group sold out of Medtronic (MDT) in Q2 2025, closing a stake of 2,467 shares — an estimated $222K sold.

Allen Capital Group first reported a position in MDT in Q2 2018 and held it in 20 quarters. The position peaked at $420K in Q4 2019. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Allen Capital Group reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Allen Capital Group sold 2,467 Medtronic shares in Q2 2025, an estimated $222K.
  • Allen Capital Group first reported a position in Medtronic in Q2 2018 and held it in 20 quarters.
  • Allen Capital Group's Medtronic position peaked at $420K in Q4 2019.
  • 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Allen Capital Group's 13F filing for Q2 2025, filed 12 Aug 2025.